Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 4, 2008
The alcoholic phenotypes among different multidimensional typologies: similarities and their classification proceduresSamuel Pombo, Otto Michael Lesch
Annals of Gastroenterology|April 10, 2014
The Lesch alcoholism typology - psychiatric and psychosocial treatment approachesGolda Schlaff, Henriette Walter, Otto Michael Lesch
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|September 20, 2005
Gender differences: does alcohol affect females more than males?Henriette Walter, Alexander Dvorak, Karin Gutierrez, et al.
The American Journal of Clinical Hypnosis|February 18, 2006
Reaction to pain stimulus before and during hypnosis measured by pupillary reactionHenriette Walter, Otto Michael Lesch, Hans Stöhr, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 7, 2007
Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptomsStephan Ruhrmann, Werner Kissling, Otto-Michael Lesch, et al.
International Journal of Psychiatry in Clinical Practice|February 11, 2015
Multidimensional alcoholism typologies: could they guide clinical practice? Results from a 3-month prospective studySamuel Pombo, Nuno Félix da Costa, Maria Luísa Figueira, et al.
European Journal of Internal Medicine|June 14, 2024
Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypesBankole Johnson, Hannu Alho, Giovanni Addolorato, et al.
Expert Opinion on Drug Safety|December 27, 2019
Post-marketing and clinical safety experience with sodium oxybate for the treatment of alcohol withdrawal syndrome and maintenance of abstinence in alcohol-dependent subjectsGiovanni Addolorato, Otto-Michael Lesch, Icro Maremmani, et al.
European Journal of Internal Medicine|March 23, 2024
Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatmentGiovanni Addolorato, Hannu Alho, Paula Bresciani M De Andrade, et al.
Journal of Clinical Psychopharmacology|May 16, 2008
Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trialMichael Soyka, Gabriele Koller, Peggy Schmidt, et al.
Pageof 2